pyrroles has been researched along with Abnormalities, Drug-Induced in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibb, H; Scialli, AR | 1 |
| Kulbertus, H | 1 |
| Anderson, JA; Dostal, LA; Schardein, JL | 1 |
3 other study(ies) available for pyrroles and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Statin drugs and congenital anomalies.
Topics: Abnormalities, Drug-Induced; Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infant, Newborn; Lovastatin; Pregnancy; Pregnancy Outcome; Pyrroles; Simvastatin | 2005 |
[The 2006 American Heart Association selection of the "top ten advances in heart disease and stroke research"].
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; American Heart Association; Anti-Inflammatory Agents; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Brain Ischemia; Child; Coronary Disease; Heart Diseases; Heart Valve Prosthesis; Heart-Assist Devices; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Obesity; Peptidyl-Dipeptidase A; Process Assessment, Health Care; Pyrroles; Stroke; Tissue Engineering; United States | 2007 |
Developmental toxicity of the HMG-CoA reductase inhibitor, atorvastatin, in rats and rabbits.
Topics: Abnormalities, Drug-Induced; Animals; Anticholesteremic Agents; Atorvastatin; Body Weight; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pregnancy; Pyrroles; Rabbits; Rats; Rats, Sprague-Dawley; Toxicity Tests | 1994 |